SPOTLIGHT: Obesity scrips top 1 million in Britain

Use of obesity drugs in Britain is up eightfold in the last seven years, to more than 1 million prescriptions; the two most popular weight-loss drugs there are orlistat (sold as Xenical by Roche) and sibutramine (sold as Reductil by Abbott Laboratories). Report | Report

Suggested Articles

It’s final: England won’t be covering AZ’s quick-selling Tagrisso in previously untreated non-small cell lung cancer patients with EGFR mutatations.

Top J&J meds have managed to hang onto market share in the face of new generics and biosims, but the drugmaker expects the pain to continue in 2020.

Lonza’s search for a new CEO is expected to be wrapped up this year as the CDMO homes in on a list of veterans from outside the company.